Gunnett C A, Chu Y, Heistad D D, Loihl A, Faraci F M
Department of Internal Medicine, University of Iowa College of Medicine, Iowa City, Iowa 52242, USA.
Am J Physiol. 1998 Aug;275(2):H416-21. doi: 10.1152/ajpheart.1998.275.2.H416.
The inducible isoform of nitric oxide synthase (iNOS) is expressed after systemic administration of lipopolysaccharide (LPS). The importance of expression of iNOS in blood vessels is poorly defined. Because nitric oxide from iNOS may alter vasomotor function, we examined effects of LPS on vasomotor function in carotid arteries from iNOS-deficient mice. We studied contraction of the carotid artery from wild-type and iNOS-deficient mice in vitro 12 h after injection of LPS (20 mg/kg ip). Contractile responses to PGF2alpha (3-30 microM) and thromboxane A2 analog (U-46619; 3-100 nM) were evaluated using vascular rings from mice treated with vehicle or LPS. Maximum force of contraction generated by rings in response to PGF2alpha was 0.39 +/- 0.02 and 0.25 +/- 0.01 (SE) g (n = 14) in vehicle and LPS-treated wild-type mice, respectively (P < 0.001 vs. vehicle). Thus LPS reduced constrictor responses in wild-type mice. Thiocitrulline and aminoguanidine (inhibitors of iNOS) improved contractile responses from LPS-treated wild-type vessels. Indomethacin also improved constrictor responses in arteries from wild-type mice injected with LPS. In contrast, contraction of the carotid arteries in response to PGF2alpha and U-46619 was not impaired in LPS-treated iNOS-deficient mice, and contraction was not altered by inhibitors of iNOS. Expression of iNOS mRNA was confirmed using RT-PCR in carotid arteries from wild-type mice after injection of LPS but not vehicle. PCR products for iNOS were not observed in iNOS-deficient mice. These findings provide the first direct evidence that iNOS mediates impairment of vascular contraction after treatment with LPS.
一氧化氮合酶(iNOS)的诱导型同工型在全身给予脂多糖(LPS)后表达。iNOS在血管中的表达重要性尚不清楚。由于来自iNOS的一氧化氮可能改变血管舒缩功能,我们研究了LPS对iNOS缺陷小鼠颈动脉血管舒缩功能的影响。我们在注射LPS(20mg/kg腹腔注射)12小时后,体外研究野生型和iNOS缺陷小鼠颈动脉的收缩情况。使用给予溶剂或LPS处理小鼠的血管环,评估对前列腺素F2α(3 - 30μM)和血栓素A2类似物(U - 46619;3 - 100 nM)的收缩反应。在给予溶剂和LPS处理的野生型小鼠中,血管环对前列腺素F2α产生的最大收缩力分别为0.39±0.02和0.25±0.01(SE)g(n = 14)(与给予溶剂相比,P < 0.001)。因此,LPS降低了野生型小鼠的收缩反应。硫代瓜氨酸和氨基胍(iNOS抑制剂)改善了LPS处理的野生型血管的收缩反应。吲哚美辛也改善了注射LPS的野生型小鼠动脉的收缩反应。相比之下,LPS处理的iNOS缺陷小鼠中,颈动脉对前列腺素F2α和U - 46619的收缩未受损,且iNOS抑制剂未改变收缩情况。在注射LPS而非溶剂的野生型小鼠颈动脉中,使用逆转录聚合酶链反应(RT - PCR)证实了iNOS mRNA的表达。在iNOS缺陷小鼠中未观察到iNOS的PCR产物。这些发现提供了首个直接证据,表明iNOS介导LPS处理后血管收缩功能的损害。